Buprenorphine + Naloxone 8/2mg, 2/0.5mg sublingual tablets (FDC)

Buprenorphine + Naloxone 8/2mg, 2/0.5mg sublingual tablets (FDC)
Product Description

Intro

Dossier:
Indication:
Formulation: 

SMB Laboratories SA

  • BE
  • 2015
    On CPHI since
Company types
Manufacturer/Innovator
Specifications

SMB Laboratories SA

  • BE
  • 2015
    On CPHI since
Company types
Manufacturer/Innovator

More Products from SMB Laboratories SA (4)